SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001136854-05-000007
Filing Date
2005-01-14
Accepted
2005-01-14 14:26:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 holdinglimitfileglfd.txt SC 13G 8087
  Complete submission text file 0001136854-05-000007.txt   9514
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45277 | Film No.: 05530305
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LOTSOFF CAPITAL MANAGEMENT 20 N CLARK ST. 34TH FL CHICAGO IL 60602-4109
Business Address C/O LOTSOFF CAPITAL MANAGEMENT 20 N CLARK ST. 34TH FL CHICAGO IL 60602-4109 3123681442
LOTSOFF CAPITAL MANAGEMENT (Filed by) CIK: 0001136854 (see all company filings)

IRS No.: 000000000 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G